Article
A review on SLE and malignancy.
Best practice & research. Clinical rheumatology - 1 Jun 2017
Choi May Y, Flood Kelsey, Bernatsky Sasha, Ramsey-Goldman Rosalind, Clarke Ann E
Abstract excerpt
Systemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disease characterized by autoantibody production, complement activation, and immune complex deposition. It predominantly affects young and middle-aged women. While improvements in the diagnosis and treatment of SLE have altered prognosis, morbidity and mortality rates remain higher than the general population. In addition to renal injury,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
